先進ドラッグデリバリーシステムの世界市場規模調査＆予測、タイプ別、用途別、技術別、地域別分析、2023-2030年

先進ドラッグデリバリーシステム（DDS）は、体内の意図した作用部位への薬物の送達を最適化するために設計された技術です。

これらのシステムは、薬物の放出、標的化、局在化を制御することにより、薬物療法の有効性、安全性、利便性を向上させることができます。先進ドラッグデリバリーシステムは、従来の薬物送達方法と比較して、薬効の向上、副作用の軽減、患者のコンプライアンス向上、利便性の向上など、多くのメリットをもたらします。また、がん、心血管疾患、神経疾患など、さまざまな疾患の治療の可能性があるため、活発に調査されています。先進ドラッグデリバリーシステム市場は、糖尿病有病率やその他の疾患の有病率の上昇、新薬や生物製剤の市場開拓、人間の生物学や疾患の理解における進歩などの要因によって拡大しています。

国際糖尿病連盟の2021年の報告書によると、インドでは2021年に7,419万4,700人の糖尿病患者が推定され、2030年にはその数が9,297万3,700人に増加すると予測されています。また、ロバート・ウッド・ジョンソン財団によると、2020年の米国における慢性疾患の発症数は1億5,700万件で、今後増加し、2030年には1億7,100万件に達すると予測されています。さらに、自己注射器の普及が進み、生物学的製剤、バイオシミラー、自己注射器などのパイプラインから、重要な医療機器のクラスが最近生まれました。多くの企業が、市場拡大を支える新鮮な製品のイントロダクション注力しています。例えば、Agile Therapeutics, Inc.は、2020年12月に米国でTwirla（levonorgestrel and ethinyl estradiol）transdermal deviceを商業的に導入します。Twirlaは、新しい非日常的、非侵襲的な避妊パッチです。さらに、2022年2月、台湾の医療用卸売業者であるShin-Ya Biotechnology Co., Ltd.が、Nu Gen Medical Devices Inc.の無針注射器InsuJetを発注しました。これは、複数年にわたる販売代理店契約の一部であり、初回の最低契約額は100,000米ドル、その後3年間は継続して契約することになっています。さらに、製剤の進歩や研究開発費の増加が、市場に有利な成長をもたらしています。しかし、先進ドラッグデリバリーシステムはコストが高いため、2023年から2030年の予測期間を通じて市場の成長を阻害しています。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を定義し、今後数年間の値を予測することです。本レポートは、調査対象国の産業の質的・量的な側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も提供しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場での潜在的な機会も組み込んでいます。.

目次

第1章 エグゼクティブサマリー

• マーケットスナップショット
• 世界市場・セグメント別市場推計・予測、2020-2030年
  • 先進ドラッグデリバリーシステム市場：地域別、2020-2030年
  • 先進ドラッグデリバリーシステム市場、タイプ別、2020-2030年
  • 先進ドラッグデリバリーシステム市場：用途別、2020-2030年
  • 先進ドラッグデリバリーシステム市場、技術別、2020-2030年
• 主要動向
• 調査手法
• 調査の前提条件

第2章 先進ドラッグデリバリーシステムの世界市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 本調査の対象範囲
• 調査対象年
• 通貨換算レート

第3章 先進ドラッグデリバリーシステムの世界市場力学

• 先進ドラッグデリバリーシステム市場の影響分析（2020年～2030年）
  • 市場促進要因
    • 新薬と生物製剤の開発
    • ヒトの生物学と疾病の理解における進歩
  • 市場の課題
    • 先進ドラッグデリバリーシステムのコスト高
  • 市場機会
    • 製剤化の進展
    • 研究開発費の増加

第4章 先進ドラッグデリバリーシステムの世界市場の産業分析

• ポーターの5フォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターの5フォース影響分析
• PEST分析
  • 政治的
  • 経済的
  • 社会的
  • 技術的
  • 環境
  • 法律
• 主要投資機会
• 主要成功戦略
• COVID-19影響度分析
• 破壊的動向
• 業界専門家の視点
• アナリストの提言と結論

第5章 先進ドラッグデリバリーシステムの世界市場：タイプ別

• 市場スナップショット
• 先進ドラッグデリバリーシステムの世界市場：タイプ別、実績、ポテンシャル分析
• 先進ドラッグデリバリーシステムの世界市場、タイプ別推定・予測（2020-2030年
• 先進ドラッグデリバリーシステム市場、サブセグメント別分析
  • 経口ドラッグデリバリーシステム
  • 注射剤型ドラッグデリバリーシステム
  • 吸入/肺薬物送達システム
  • 経皮ドラッグデリバリーシステム
  • 経粘膜ドラッグデリバリーシステム
  • キャリア型ドラッグデリバリーシステム
  • その他のタイプ

第6章 先進ドラッグデリバリーシステムの世界市場：用途別

• 市場スナップショット
• 先進ドラッグデリバリーシステムの世界市場：用途別、実績、ポテンシャル分析
• 先進ドラッグデリバリーシステムの世界市場、用途別推定・予測2020-2030
• 先進ドラッグデリバリーシステム市場、サブセグメント別分析
  • 心血管疾患
  • オンコロジー
  • 泌尿器科
  • 糖尿病
  • 中枢神経系
  • 眼科
  • その他

第7章 先進ドラッグデリバリーシステムの世界市場：技術別

• 市場スナップショット
• 先進ドラッグデリバリーシステムの世界市場：技術別、実績、ポテンシャル分析
• 先進ドラッグデリバリーシステムの世界市場、技術別推定・予測2020～2030年
• 先進ドラッグデリバリーシステム市場、サブセグメント別分析
  • プロドラッグ
  • インプラント・子宮内デバイス
  • ターゲットドラッグデリバリー
  • ポリメリックドラッグデリバリー
  • その他の技術

第8章 先進ドラッグデリバリーシステムの世界市場：地域別分析

• 上位の主要国
• 上位新興国
• 先進ドラッグデリバリーシステム市場、地域別市場スナップショット
• 北米
  • 米国
    • タイプ別推定・予測、2020-2030年
    • 用途別の推定・予測、2020-2030年
    • 技術の内訳の推定と予測、2020-2030年
  • カナダ
• 欧州先進ドラッグデリバリーシステム市場スナップショット
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• アジア太平洋の先進ドラッグデリバリーシステム市場スナップショット
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカの先進ドラッグデリバリーシステム市場スナップショット
  • ブラジル
  • メキシコ
• 中東・アフリカ地域
  • サウジアラビア
  • 南アフリカ
  • その他中東とアフリカ

第9章 競合情報

• 主要企業のSWOT分析
  • 企業1
  • 企業2
  • 企業3
• 主要市場戦略
• 企業プロファイル
  • Becton, Dickinson and Company
    • 主要情報
    • 概要
    • 財務情報（データの入手が可能な場合のみ）
    • 製品概要
    • 最近の動向
  • Abbott Laboratories
  • Bayer AG
  • Boston Scientific Corporation
  • Kindeva Drug Delivery L.P.
  • Johnson & Johnson Pvt Ltd
  • Pfizer Inc.
  • Novartis AG
  • Medtronic
  • Ypsomed

第10章 調査プロセス

• 調査プロセス
  • データマイニング
  • 分析
  • 市場推定
  • バリデーション
  • 出版
• 調査の特徴
• 調査の前提条件

LIST OF TABLES

• TABLE 1. Global Advanced Drug Delivery Systems Market, report scope
• TABLE 2. Global Advanced Drug Delivery Systems Market estimates & forecasts by Region 2020-2030 (USD Billion)
• TABLE 3. Global Advanced Drug Delivery Systems Market estimates & forecasts by Type 2020-2030 (USD Billion)
• TABLE 4. Global Advanced Drug Delivery Systems Market estimates & forecasts by Application 2020-2030 (USD Billion)
• TABLE 5. Global Advanced Drug Delivery Systems Market estimates & forecasts by Technology 2020-2030 (USD Billion)
• TABLE 6. Global Advanced Drug Delivery Systems Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 7. Global Advanced Drug Delivery Systems Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 8. Global Advanced Drug Delivery Systems Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 9. Global Advanced Drug Delivery Systems Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 10. Global Advanced Drug Delivery Systems Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 11. Global Advanced Drug Delivery Systems Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 12. Global Advanced Drug Delivery Systems Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 13. Global Advanced Drug Delivery Systems Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 14. Global Advanced Drug Delivery Systems Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 15. Global Advanced Drug Delivery Systems Market by region, estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 16. U.S. Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 17. U.S. Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 18. U.S. Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 19. Canada Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 20. Canada Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 21. Canada Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 22. UK Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 23. UK Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 24. UK Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 25. Germany Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 26. Germany Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 27. Germany Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 28. France Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 29. France Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 30. France Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 31. Italy Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 32. Italy Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 33. Italy Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 34. Spain Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 35. Spain Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 36. Spain Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 37. RoE Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 38. RoE Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 39. RoE Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 40. China Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 41. China Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 42. China Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 43. India Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 44. India Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 45. India Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 46. Japan Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 47. Japan Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 48. Japan Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 49. South Korea Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 50. South Korea Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 51. South Korea Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 52. Australia Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 53. Australia Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 54. Australia Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 55. RoAPAC Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 56. RoAPAC Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 57. RoAPAC Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 58. Brazil Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 59. Brazil Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 60. Brazil Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 61. Mexico Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 62. Mexico Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 63. Mexico Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 64. RoLA Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 65. RoLA Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 66. RoLA Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 67. Saudi Arabia Advanced Drug Delivery Systems Market estimates & forecasts, 2020-2030 (USD Billion)
• TABLE 68. South Africa Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 69. RoMEA Advanced Drug Delivery Systems Market estimates & forecasts by segment 2020-2030 (USD Billion)
• TABLE 70. List of secondary sources, used in the study of global Advanced Drug Delivery Systems Market
• TABLE 71. List of primary sources, used in the study of global Advanced Drug Delivery Systems Market
• TABLE 72. Years considered for the study
• TABLE 73. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

• FIG 1. Global Advanced Drug Delivery Systems Market, research methodology
• FIG 2. Global Advanced Drug Delivery Systems Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Advanced Drug Delivery Systems Market, key trends 2022
• FIG 5. Global Advanced Drug Delivery Systems Market, growth prospects 2023-2030
• FIG 6. Global Advanced Drug Delivery Systems Market, porters 5 force model
• FIG 7. Global Advanced Drug Delivery Systems Market, pest analysis
• FIG 8. Global Advanced Drug Delivery Systems Market, value chain analysis
• FIG 9. Global Advanced Drug Delivery Systems Market by segment, 2020 & 2030 (USD Billion)
• FIG 10. Global Advanced Drug Delivery Systems Market by segment, 2020 & 2030 (USD Billion)
• FIG 11. Global Advanced Drug Delivery Systems Market by segment, 2020 & 2030 (USD Billion)
• FIG 12. Global Advanced Drug Delivery Systems Market by segment, 2020 & 2030 (USD Billion)
• FIG 13. Global Advanced Drug Delivery Systems Market by segment, 2020 & 2030 (USD Billion)
• FIG 14. Global Advanced Drug Delivery Systems Market, regional snapshot 2020 & 2030
• FIG 15. North America Advanced Drug Delivery Systems Market 2020 & 2030 (USD Billion)
• FIG 16. Europe Advanced Drug Delivery Systems Market 2020 & 2030 (USD Billion)
• FIG 17. Asia pacific Advanced Drug Delivery Systems Market 2020 & 2030 (USD Billion)
• FIG 18. Latin America Advanced Drug Delivery Systems Market 2020 & 2030 (USD Billion)
• FIG 19. Middle East & Africa Advanced Drug Delivery Systems Market 2020 & 2030 (USD Billion)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Advanced Drug Delivery Systems Market is valued at approximately USD XXX billion in 2022 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2023-2030. Advanced drug delivery systems (DDS) are technologies designed to optimize the delivery of drugs to their intended site of action in the body. These systems can enhance the efficacy, safety, and convenience of drug therapy by controlling the release, targeting, and localization of the drug. Advanced drug delivery systems offer numerous benefits over traditional drug delivery methods, including improved drug efficacy, reduced side effects, increased patient compliance, and enhanced convenience. They are also being actively researched for their potential to treat a wide range of diseases, including cancer, cardiovascular disease, and neurological disorders. The Advanced Drug Delivery Systems Market is expanding because of factors such as rising diabetes prevalence and prevalence of other diseases, the Development of new drugs and biologics and advancements in understanding human biology and diseases.

The rising prevalence of chronic diseases and cardiac vascular diseases is catering the market growth. according to a 2021 report from the International Diabetes Federation, India had an estimated 74,194.7 thousand cases of diabetes in 2021, and by 2030, that number is predicted to rise to 92,973.7 thousand cases. Furthermore, according to Robert Wood Johnson Foundation, in the year 2020, the incidences of chronic illness in the United States stood at 157 million cases which is projected to increase and reach 171 million cases by the year 2030. Furthermore, Self-injecting devices are becoming increasingly popular, and a significant class of medical devices has also recently arisen from the pipeline of biologics, biosimilars, and auto-injectors. A lot of businesses are concentrating on the introduction of fresh products that will support market expansion. For instance, Agile Therapeutics, Inc. commercially introduce Twirla (levonorgestrel and ethinyl estradiol) transdermal device in the United States in December 2020. Twirla is a new non-daily, non-invasive contraceptive patch. Additionally, in February 2022, Shin-Ya Biotechnology Co., Ltd., a Taiwanese medical wholesaler, placed an order for Nu Gen Medical Devices Inc.'s InsuJet needleless injection system. This is a component of a multi-year sales and distribution deal with an initial minimum commitment of USD 100,000 CDN and subsequent commitments for the following three years. In addition, advancements in Formulation and increased R&D Spending are creating lucrative growth in the market. However, the high cost of Advanced Drug Delivery Systems stifles market growth throughout the forecast period of 2023-2030.

Major market players included in this report are:

• Becton, Dickinson and Company
• Abbott Laboratories
• Bayer AG
• Boston Scientific Corporation
• Kindeva Drug Delivery L.P.
• Johnson & Johnson Pvt Ltd
• Pfizer Inc.
• Novartis AG
• Medtronic
• Ypsomed

Recent Developments in the Market:

• In March 2022, The FDA has given approval for Corium, Inc.'s ADLARITY (donepezil transdermal system) as a medication for people with Alzheimer's-related dementia who have mild, moderate, or severe symptoms. The only once-weekly patch that constantly and consistently administers doses of donepezil through the skin is ADLARITY.
• In March 2022, The US Food and Drug Administration has authorised the first generic form of Symbicort (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol for the treatment of two common pulmonary illnesses: COPD, which includes chronic bronchitis and/or emphysema, and asthma in patients six years of age and older.

Global Advanced Drug Delivery Systems Market Report Scope:

• Historical Data: - 2020 - 2021
• Base Year for Estimation: - 2022
• Forecast period: - 2023-2030
• Report Coverage: - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered: -, Type, Application, Technology, Region
• Regional Scope: - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope: - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Type:

• Oral Drug Delivery System
• Injection-based Drug Delivery System
• Inhalation/Pulmonary Drug Delivery System
• Transdermal Drug Delivery System
• Trans mucosal Drug Delivery System
• Carrier-based Drug Delivery System
• Other Types

By Application:

• Cardiovascular Diseases
• Oncology
• Urology
• Diabetes
• Central Nervous System
• Ophthalmology
• Others

By Technology:

• Prodrug
• Implants and Intrauterine Devices
• Targeted Drug Delivery
• Polymeric Drug Delivery
• Other Technologies

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
  • 1.2.1. Advanced Drug Delivery Systems Market, by Region, 2020-2030 (USD Billion)
  • 1.2.2. Advanced Drug Delivery Systems Market, by Type, 2020-2030 (USD Billion)
  • 1.2.3. Advanced Drug Delivery Systems Market, by Application, 2020-2030 (USD Billion)
  • 1.2.4. Advanced Drug Delivery Systems Market, by Technology, 2020-2030 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Advanced Drug Delivery Systems Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Industry Evolution
  • 2.2.2. Scope of the Study
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Advanced Drug Delivery Systems Market Dynamics

• 3.1. Advanced Drug Delivery Systems Market Impact Analysis (2020-2030)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Development of New Drugs and Biologics
    • 3.1.1.2. Advancements in Understanding Human Biology and Diseases
  • 3.1.2. Market Challenges
    • 3.1.2.1. High Cost of Advanced Drug Delivery Systems
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Advancements in Formulation
    • 3.1.3.2. Increased R&D Spending

Chapter 4. Global Advanced Drug Delivery Systems Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
• 4.2. Porter's 5 Force Impact Analysis
• 4.3. PEST Analysis
  • 4.3.1. Political
  • 4.3.2. Economical
  • 4.3.3. Social
  • 4.3.4. Technological
  • 4.3.5. Environmental
  • 4.3.6. Legal
• 4.4. Top investment opportunity
• 4.5. Top winning strategies
• 4.6. COVID-19 Impact Analysis
• 4.7. Disruptive Trends
• 4.8. Industry Expert Perspective
• 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Advanced Drug Delivery Systems Market, by Type

• 5.1. Market Snapshot
• 5.2. Global Advanced Drug Delivery Systems Market by Type, Performance - Potential Analysis
• 5.3. Global Advanced Drug Delivery Systems Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
• 5.4. Advanced Drug Delivery Systems Market, Sub Segment Analysis
  • 5.4.1. Oral Drug Delivery System
  • 5.4.2. Injection-based Drug Delivery System
  • 5.4.3. Inhalation/Pulmonary Drug Delivery System
  • 5.4.4. Transdermal Drug Delivery System
  • 5.4.5. Trans mucosal Drug Delivery System
  • 5.4.6. Carrier-based Drug Delivery System
  • 5.4.7. Other Types

Chapter 6. Global Advanced Drug Delivery Systems Market, by Application

• 6.1. Market Snapshot
• 6.2. Global Advanced Drug Delivery Systems Market by Application, Performance - Potential Analysis
• 6.3. Global Advanced Drug Delivery Systems Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
• 6.4. Advanced Drug Delivery Systems Market, Sub Segment Analysis
  • 6.4.1. Cardiovascular Diseases
  • 6.4.2. Oncology
  • 6.4.3. Urology
  • 6.4.4. Diabetes
  • 6.4.5. Central Nervous System
  • 6.4.6. Ophthalmology
  • 6.4.7. Others

Chapter 7. Global Advanced Drug Delivery Systems Market, by Technology

• 7.1. Market Snapshot
• 7.2. Global Advanced Drug Delivery Systems Market by Technology, Performance - Potential Analysis
• 7.3. Global Advanced Drug Delivery Systems Market Estimates & Forecasts by Technology 2020-2030 (USD Billion)
• 7.4. Advanced Drug Delivery Systems Market, Sub Segment Analysis
  • 7.4.1. Prodrug
  • 7.4.2. Implants and Intrauterine Devices
  • 7.4.3. Targeted Drug Delivery
  • 7.4.4. Polymeric Drug Delivery
  • 7.4.5. Other Technologies

Chapter 8. Global Advanced Drug Delivery Systems Market, Regional Analysis

• 8.1. Top Leading Countries
• 8.2. Top Emerging Countries
• 8.3. Advanced Drug Delivery Systems Market, Regional Market Snapshot
• 8.4. North America Advanced Drug Delivery Systems Market
  • 8.4.1. U.S. Advanced Drug Delivery Systems Market
    • 8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3. Technology breakdown estimates & forecasts, 2020-2030
  • 8.4.2. Canada Advanced Drug Delivery Systems Market
• 8.5. Europe Advanced Drug Delivery Systems Market Snapshot
  • 8.5.1. U.K. Advanced Drug Delivery Systems Market
  • 8.5.2. Germany Advanced Drug Delivery Systems Market
  • 8.5.3. France Advanced Drug Delivery Systems Market
  • 8.5.4. Spain Advanced Drug Delivery Systems Market
  • 8.5.5. Italy Advanced Drug Delivery Systems Market
  • 8.5.6. Rest of Europe Advanced Drug Delivery Systems Market
• 8.6. Asia-Pacific Advanced Drug Delivery Systems Market Snapshot
  • 8.6.1. China Advanced Drug Delivery Systems Market
  • 8.6.2. India Advanced Drug Delivery Systems Market
  • 8.6.3. Japan Advanced Drug Delivery Systems Market
  • 8.6.4. Australia Advanced Drug Delivery Systems Market
  • 8.6.5. South Korea Advanced Drug Delivery Systems Market
  • 8.6.6. Rest of Asia Pacific Advanced Drug Delivery Systems Market
• 8.7. Latin America Advanced Drug Delivery Systems Market Snapshot
  • 8.7.1. Brazil Advanced Drug Delivery Systems Market
  • 8.7.2. Mexico Advanced Drug Delivery Systems Market
• 8.8. Middle East & Africa Advanced Drug Delivery Systems Market
  • 8.8.1. Saudi Arabia Advanced Drug Delivery Systems Market
  • 8.8.2. South Africa Advanced Drug Delivery Systems Market
  • 8.8.3. Rest of Middle East & Africa Advanced Drug Delivery Systems Market

Chapter 9. Competitive Intelligence

• 9.1. Key Company SWOT Analysis
  • 9.1.1. Company 1
  • 9.1.2. Company 2
  • 9.1.3. Company 3
• 9.2. Top Market Strategies
• 9.3. Company Profiles
  • 9.3.1. Becton, Dickinson and Company
    • 9.3.1.1. Key Information
    • 9.3.1.2. Overview
    • 9.3.1.3. Financial (Subject to Data Availability)
    • 9.3.1.4. Product Summary
    • 9.3.1.5. Recent Developments
  • 9.3.2. Abbott Laboratories
  • 9.3.3. Bayer AG
  • 9.3.4. Boston Scientific Corporation
  • 9.3.5. Kindeva Drug Delivery L.P.
  • 9.3.6. Johnson & Johnson Pvt Ltd
  • 9.3.7. Pfizer Inc.
  • 9.3.8. Novartis AG
  • 9.3.9. Medtronic
  • 9.3.10. Ypsomed

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption